|
COL4A3BP expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.746420E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.381700E-02 |
| Normal-vs-Stage2 |
4.062600E-01 |
| Normal-vs-Stage3 |
2.898700E-03 |
| Normal-vs-Stage4 |
6.238500E-04 |
| Stage1-vs-Stage2 |
4.876800E-01 |
| Stage1-vs-Stage3 |
1.566640E-01 |
| Stage1-vs-Stage4 |
2.262300E-02 |
| Stage2-vs-Stage3 |
1.546380E-01 |
| Stage2-vs-Stage4 |
4.962500E-02 |
| Stage3-vs-Stage4 |
3.820200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.744800E-03 |
| Normal-vs-AfricanAmerican |
7.147400E-01 |
| Normal-vs-Asian |
1.082320E-02 |
| Caucasian-vs-AfricanAmerican |
2.774400E-01 |
| Caucasian-vs-Asian |
5.489400E-01 |
| AfricanAmerican-vs-Asian |
1.910850E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.993800E-02 |
| Normal-vs-Female |
1.776350E-02 |
| Male-vs-Female |
9.531000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.915800E-02 |
| Normal-vs-Age(41-60Yrs) |
3.523600E-02 |
| Normal-vs-Age(61-80Yrs) |
2.843900E-03 |
| Normal-vs-Age(81-100Yrs) |
3.713800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.329000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.531770E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.565600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.558800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.575400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.194800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.260500E-02 |
| Classical-VS-Follicular |
1.049590E-02 |
| Classical-VS-Other |
1.659150E-01 |
| Classical-VS-Normal |
1.569770E-02 |
| Tall-VS-Follicular |
3.368300E-04 |
| Tall-VS-Other |
4.348200E-01 |
| Tall-VS-Normal |
2.600100E-04 |
| Follicular-VS-Other |
5.561600E-02 |
| Follicular-VS-Normal |
8.259800E-01 |
| Other-VS-Normal |
1.858090E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.248000E-02 |
| Normal-vs-N1 |
1.221030E-03 |
| N0-vs-N1 |
6.396000E-02 |
|
|
